Director, Clinical Compliance
Jade Biosciences
| Company | Jade Biosciences |
| Category | Healthcare |
| Location | Remote; San Francisco; Seattle |
| Remote | Remote |
| Employment | Not stated |
| Level | Director |
| Salary | Not stated by the employer |
| Posted | 18 Jun 2026 |
| Last verified | 12 Aug 2026 |
| Source | Employer ATS (greenhouse) |
Description
About Jade Biosciences
Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases. Jade’s lead candidate, JADE101, targets the cytokine APRIL, and is currently being evaluated in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. Jade’s pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, as well as JADE301, an undisclosed antibody candidate, both currently in preclinical development. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount. For more information, visit JadeBiosciences.com and follow the Company on LinkedIn . Role Overview
The Director, Clinical Compliance collaborates with internal and external stakeholders to ensure that clinical trials conducted by Jade adhere to ICH-GCP, regulatory requirements, internal SOPs, and quality standards. Embedded within the Development Operations Operational Excellence team, this role functions as an internal GCP compliance leader who partners closely with study teams, vendors, and Quality Assurance (QA) to maintain inspection readiness and operational quality across all clinical programs. This individual will lead initiatives related to vendor oversight, monitoring oversight, compliance metrics and issue management and escalation, while serving as a key liaison between Clinical Operations and the GCP Quality organization during audits and regulatory inspections.
Key Responsibilities
Clinical Compliance Oversight
Serve as a trusted GCP compliance advisor to all functions within study teams by promoting a culture of quality and helping teams integrate compliant practices into daily study execution and decision-making
Analyze compliance metrics, audit findings, monitoring data, and operational trends across programs to identify systemic risks and opportunities for process improvement
Apply risk-based judgment in interpreting and implementing GCP requirements, balancing regulatory expectations with operational realities to ensure compliance approaches are practical, defensible, and appropriate to the level of risk
Inspection Readiness
Drive initiatives to ensure continuous inspection readiness across clinical studies
Assist in preparation for regulatory inspections and internal audits including readiness assessments and document reviews
Support development of inspection storyboards and response strategies when needed
Ensure study teams maintain inspection-ready documentation and evidence of ongoing compliance
Vendor Oversight & KPI Monitoring
Support oversight of CROs and other clinical vendors to ensure compliance with contractual and regulatory expectations
Partner with Development Outsourcing on defining and tracking vendor performance metrics and KPIs
Participate in vendor governance meetings and performance reviews
Identify trends or risks in vendor performance and recommend mitigation strategies
Review and track vendor QEs
Monitoring Oversight
Develop processes for oversight of monitoring activities conducted by CROs
Review monitoring oversight plans, reports, and monitoring metrics
Assess monitoring quality and compliance with monitoring plans
Identify monitoring gaps and collaborate with study teams to address them
Non-Compliance Management
Support identification and management of investigator or site non-compliance
Assist study teams in evaluating protocol deviations and escalation needs
Help develop remediation strategies for significant compliance issues
Issue Management and Escalation
Support study teams in identifying and appropriately escalating significant compliance issues, protocol deviations, and site noncompliance, ensuring issues are investigated, documented, and resolved in accordance with regu